Publicaciones en colaboración con investigadores/as de Novartis (Sweden) (23)

2020

  1. HuR/ELAVL1 drives malignant peripheral nerve sheath tumor growth and metastasis

    The Journal of clinical investigation, Vol. 130, Núm. 7, pp. 3848-3864

2019

  1. Adjuvant therapy versus watch-and-wait post surgery for stage III melanoma: A multicountry retrospective chart review

    Melanoma Management, Vol. 6, Núm. 4

2018

  1. Comparison of incision size and intraocular lens performance after implantation with three preloaded systems and one manual delivery system

    Clinical Ophthalmology, Vol. 12, pp. 1495-1503

  2. Phase II study of buparlisib (BKM120) and trastuzumab in patients with HER2+ locally advanced or metastatic breast cancer resistant to trastuzumab-based therapy

    Breast Cancer Research and Treatment, Vol. 168, Núm. 2, pp. 357-364

2014

  1. Phase lb study of buparlisib plus trastuzumab in patients with HER2-positive advanced or metastatic breast cancer that has progressed on trastuzumab-based therapy

    Clinical Cancer Research, Vol. 20, Núm. 7, pp. 1935-1945

2013

  1. Design, synthesis, and functional evaluation of leukocyte function associated antigen-1 antagonists in early and late stages of cancer development

    Journal of Medicinal Chemistry, Vol. 56, Núm. 3, pp. 735-747

2010

  1. Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study

    Leukemia Research, Vol. 34, Núm. 9, pp. 1143-1150

  2. Effect of nateglinide on the incidence of diabetes and cardiovascular events

    New England Journal of Medicine, Vol. 362, Núm. 16, pp. 1463-1476

  3. Effect of valsartan on the incidence of diabetes and cardiovascular events

    New England Journal of Medicine, Vol. 362, Núm. 16, pp. 1477-1490

2007

  1. Molecular response to aromatase inhibitor treatment in primary breast cancer

    Breast Cancer Research, Vol. 9, Núm. 3

2006

  1. Immunocytochemical localization of metabotrophic (mGluR2/3 and mGluR4a) and ionotropic (GluR2/3) glutamate receptors in adrenal medullary ganglion cells

    Histology and Histopathology, Vol. 21, Núm. 1-3, pp. 141-147

2005

  1. Immunoreactivity for the group III receptor subtype mGluR4a in the visual layers of the rat superior colliculus

    Neuroscience, Vol. 131, Núm. 3, pp. 627-633

2002

  1. Dietary fatty acid composition affects aminopeptidase activities in the testes of mice

    International Journal of Andrology, Vol. 25, Núm. 2, pp. 113-118

2001

  1. Immunoreactivity for the group III metabotropic glutamate receptor subtype mGluR4a in the superficial laminae of the rat spinal dorsal horn

    Journal of Comparative Neurology, Vol. 430, Núm. 4, pp. 448-457

2000

  1. Immunocytochemical localization of the metabotropic glutamate receptor mGluR4a in the piriform cortex of the rat

    Journal of Comparative Neurology, Vol. 417, Núm. 3, pp. 263-274

  2. Immunolocalization of the mGluR1b splice variant of the metabotropic glutamate receptor 1 at parallel fiber-Purkinje cell synapses in the rat cerebellar cortex

    Journal of Neurochemistry, Vol. 74, Núm. 3, pp. 1301-1309

1999

  1. Clustering of the group III metabotropic glutamate receptor 4a at parallel fiber synaptic terminals in the rat cerebellar molecular layer

    Neuroscience Research, Vol. 35, Núm. 1, pp. 71-74

  2. Developmental expression of the group III metabotropic glutamate receptor mGluR4a in the medial nucleus of the trapezoid body of the rat

    Journal of Comparative Neurology, Vol. 411, Núm. 3, pp. 431-440

  3. Distribution of the group II metabotropic glutamate receptors (mGluR2/3) in the enteric nervous system of the rat

    Neuroscience Letters, Vol. 276, Núm. 2, pp. 91-94

1998

  1. Immunocytochemical localization of the mGluR1b metabotropic glutamate receptor in the rat hypothalamus

    Journal of Comparative Neurology, Vol. 390, Núm. 2, pp. 225-233